Advise neomycin-sensitive patients to avoid the ... Ciloxan® ophthalmic ointment and solution (cipro-floxacin), Vigamox® ophthalmic solution (moxifloxacin), Ocuflox® ophthalmic solution ...

The phase 3 trial observed the treatment of chronic night driving impairment in keratorefractive patients with reduced ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

In a phase 3 clinical trial, chronic night driving impairment in patients who underwent keratorefractive procedures improved ...

Phentolamine Ophthalmic Solution 0.75% is designed to reduce pupil diameter through a sympatholytic mechanism of action that avoids engaging the ciliary muscle, potentially reducing risks such as ...

For whatever reason, I’ve been home a lot recently.

These disturbances can significantly impair night driving and daily functioning in dim environments. Phentolamine Ophthalmic Solution 0.75% is designed to reduce pupil diameter through a sympatholytic ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

Benjamin Bergstrom, DVM, MS, DACVO, helps general practitioners distinguish between these two commonly confused conditions ...